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Background
The holocaust and its psychological consequences in old
age
The Holocaust was one of the most traumatic catastro-
phes in recorded human history. Over the span of sev-
eral years, a multitude of traumatic events were
experienced by a large group of people: persecution and
flight under threat of death, loss of family members,
starvation, fighting, rape, forced displacement, concen-
tration or extermination camps, torture, witnessing tor-
ture and death and being forced to survive in hiding etc.
The majority of Holocaust survivors alive at present
(now in their seventies and eighties or older) were chil-
dren and teenagers during the years of the Holocaust. In
addition to experiencing traumatic stressors, being a
child or adolescent before, during and even after the
Second World War (WWII) also meant experiencing
massive losses and being separated from parents, rela-
tives and home [1].
Survivors grown old, seeking psychotherapeutic treat-
ment today, exhibit a deterioration of the capability to
deal with the burden of the past by a depressed, or irrit-
able mood as a result of an underlying posttraumatic
stress disorder (PTSD). The mental health of Holocaust
survivors is in average still worse today than a compari-
son group, mainly with regard to PTSD symptoms, de-
pression and anxiety [2]. The majority of Holocaust
survivors show a chronic course, i.e. they experience a
steady decrease of PTSD symptom severity, whereas
about 10% of survivors show a delayed course, i.e. symp-
toms increase over time or get reactivated after a long
symptom-free time [3].
Although Holocaust survivors exhibit incredible adap-
tive processes [4], aging poses new challenges for this
adaptation process. Aging is accompanied by reviewing
one’s life in order to evaluate gains and losses and find
meaning [5]. When old people engage in retrospection,
past memories might evoke those early experiences of
trauma, loss and deprivation and induce or intensify
symptoms of PTSD, anxiety, depression and grief. In
addition, confrontation with new crises (e.g. retirement),
losses (persons, resources, physical and mental decline)
and traumatic events (e.g. wars) might further conjure
up those childhood memories and intensify symptoms
[6]. Living in Israel is especially characterised by a con-
stant feeling of danger and looming threat due to the
political instability and ongoing threat of war in the
Middle East.
State of treatment research
Established PTSD treatments
Most PTSD treatment research has focused on children
and young and middle-aged adults. The need for psy-
chotherapy for the elderly, especially for those who
suffer from PTSD, has not been subject to systematic
study up until very recently [7]. Established psycho-
logical treatments for PTSD can be roughly divided into
(a) trauma-focused approaches including exposure and
cognition-focused approaches (e.g. cognitive behaviour
therapies, CBT, eye movement desensitisation and
reprocessing and narrative exposure) and (b) approaches
with a broader focus, i.e. not only on the trauma, but
also on associated problems such as guilt, anger, grief
and depression (e.g. psychodynamic therapies, PDT and
non-directive counselling). In addition (c), trauma-
focused (i.e. cognitive and behavioural) interventions are
often integrated into a psychodynamic treatment.
RCTs on PTSD treatment in old age are very scarce.
We identified two RCTs that examined this age group.
An internet-based writing therapy called Integrative Tes-
timonial Therapy (ITT) with WWII survivors combining
cognitive-behavioural and life review elements found
moderate decreases in PTSD symptoms [8, 9]. A pro-
longed exposure therapy with older veterans with PTSD
as a result of their military service found treatment gains
from pre- to posttest, but those gains were lost in the
follow-up [10, 11].
Narrative approaches integrate exposure and cognitive
interventions [e.g., [12]], their efficacy has been proven
[13], but not in old age so far. Narrative approaches aim
at reconstructing the memories of traumatic events and
transforming them into a coherent narrative (exposure
focus), integrating those memories into the biography
and reassessing the meaning of the events (cognition
focus).
Treatment of holocaust survivors in Israel
The most often offered treatment of Holocaust survivors
in Israel is based on a psychodynamic understanding
which integrates trauma-focused elements, i.e. imaginary
or behavioural exposure, cognitive reappraisal and narra-
tive techniques [14]. “Brief psychodynamic therapy” [15]
is very often applied in the treatment of trauma patients.
One randomised controlled trial (RCT) without older
patients showed that it is more effective than the waiting
list control group and similarly effective as trauma-
focused therapy [16]. However, the treatments that have
been shown to be effective in early and middle adult-
hood have just started to get systematically investigated
in old age, and there is no randomised, controlled study
with Holocaust survivors.
Amcha, the “National Israeli Center for Psychosocial
Support of Survivors of the Holocaust and the Second
Generation”, is a pioneer in helping and treating Holo-
caust survivors, and adapted an integrative psycho-
dynamic approach [17]. Amcha has been founded in
1987 by a group of Holocaust survivors and mental
health professionals with the goal (as a non-profit
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organisation) to support and treat survivors and their
families with psychosocial interventions (mainly psycho-
therapy and social clubs). Amcha has steadily expanded
over the 30 years of its existence. Today there are 15
centres in Israel that operate throughout the country.
Most of the professionals are trained psychotherapists –
psychiatrists, psychologists and social workers. About
8700 Holocaust survivors are currently treated by
Amcha. Given the lack of efficacy studies of psycho-
dynamic PTSD treatment in old age, it is needless to
state that the efficacy of the treatment offered at Amcha
has not been investigated so far.
Life review therapy as an age-specific treatment of PTSD
One approach to the treatment of older PTSD patients
is to apply the established psychological therapies de-
scribed above with minor adaptations [e.g., [11, 18]].
However, the question arises whether an age-specific
treatment of PTSD would be more adequate. Aging is
accompanied with reviewing one’s life in order to evalu-
ate gains and losses and to find meaning [5]. Therefore,
a narrative approach as mentioned above seems to meet
very well the natural need of older people to review their
lives [19]. Most studies on the efficacy of life review
therapy (LRT) focus on late-life depression. A meta-
analysis comparing the effect of life-review, CBT, PDT
and other treatments on clinically depressed older adults
found large effect sizes for LRT and CBT and medium
effect sizes for PDT [20]. However, there is a lack of effi-
cacy studies evaluating the effect of life-review therapy
on PTSD symptoms in older individuals that have expe-
rienced traumatic events during their lives [19]. This is
particularly surprising since there are very good experi-
ences with narrative approaches in the treatment of
PTSD with children, adolescents and young and middle-
aged adults [13]. Maercker [21] combined the life-review
therapy approach [22] with narrative exposure to the
traumatic events such as in narrative exposure therapy
[12]. He reported on three case studies that found this
life-review therapy to be effective in German survivors
of the Nazi period [21]. Building on these case studies,
Knaevelsrud et al. [8] developed the Integrative Testimo-
nial Therapy (ITT) approach, an internet-based writing
therapy that integrates life-review therapy with narrative
exposure and cognitive restructuring. Preliminary results
of a pre-post follow-up study with a sample of older
PTSD patients who were traumatised as children during
WWII indicate that this therapy significantly reduces
PTSD and anxiety symptoms.
While there is no controlled study on the efficacy of
LRT with Holocaust survivors, experimental and narra-
tive research on life stories of Holocaust survivors sup-
ports the assumption that it would be effective in this
sample. For example, it was shown that the degree of
disclosure during the telling of their story was positively
correlated with long-term health [23]. Furthermore, in a
longitudinal case study, one Holocaust survivor was sys-
tematically interviewed twice, in 1982 and 1995 [24]. It
was found that while structure and general content of
the narratives remain highly consistent over time, the
later narrative was more fully developed and integrated
new interpretations as well as historical insights. This
qualitative finding suggests that Holocaust survivors
might be open for re-evaluating their lives when review-
ing major events.
The need for a trial
From the previous literature review follows that not only
the traditional, age-unspecific approaches (PDT, CBT),
but also the age-specific LRT have not been evaluated
with state-of-the-art methodology in Holocaust survi-
vors. Therefore, an RCT that investigates the efficacy of
LRT (as an age-specific trauma treatment) is urgently
needed [25].
Study objectives
To our knowledge, there is no controlled study evaluat-
ing the efficacy of psychotherapy in Holocaust survivors.
Therefore, the general goal of this study is to evaluate
the efficacy of an integrative, age-specific treatment of
PTSD and related mental health problems (depression,
anxiety, prolonged grief) in Holocaust survivors.
From the previous research outlined above follows that
LRT, which not only meets the natural needs of older
people to review their lives, but is also effective in the
treatment of depression (as shown by several RCTs) and
PTSD (as shown by case studies and preliminary results
from one RCT), seems to be most promising for the
treatment of Holocaust survivors.
Part of the basic support structure of Holocaust survi-
vors in Israel are social support services, which are also
provided by all Amcha centres throughout the country
(called “social club”). The social clubs are meant to let
survivors come together in an environment where they
meet people with whom they share common experiences
now and then. The clubs provide activities like films, lec-
tures, courses in art, music, memory improvement, gym-
nastics, languages (English, Yiddish), visits to interesting
places, birthday celebrations, discussions of relevant is-
sues, etc. They are not intended for psychodynamic or
trauma-focused psychotherapy.
Thus, in this study, participants receiving the treat-
ment (LRT) are explicitly allowed to continue visiting
the social club. The control group consists of social club
member who receive no psychotherapeutic treatment
(LRT or other). Control group participants might receive
LRT after the follow-up assessment.
The goals of this study are:
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1. to evaluate the effect of LRT for Holocaust
survivors (LRT-HS), in addition to attending the
“social club”, on symptoms of PTSD and related
mental health problems (depression, anxiety,
prolonged grief), compared to a supportive control
group (“social club”);
2. to identify groups of participants that seem to
especially benefit from the treatment.
Two research questions will be investigated:
1. Does the LRT-HS as short-term treatment for
Holocaust survivors, in addition to attending the
“social club”, reduce the symptoms of PTSD and re-
lated mental health problems (depression, anxiety,
prolonged grief) more than a supportive control
group (only attending the “social club”)?
We expect that life-review therapy will reduce the
symptoms of PTSD and related mental health problems
with a large pre-post effect size and to a greater extent
than the supportive control group at posttest and 6-
months follow-up with a medium-to-large effect size.
2. Which factors moderate the treatment effect, i.e.
which factors influence who benefits most from the
intervention?
We expect that LRT-HS will have a greater effect in
people (a) with more severe symptoms of PTSD, depres-
sion, anxiety and/or grief at pretest, (b) with lower posi-
tive well-being and posttraumatic growth at pretest, (c)
of female gender, (d) with higher cognitive status at pre-
test, (e) with higher trauma severity, i.e. number of trau-
matic events, months/years experienced during the




The proposed study is a randomised, controlled follow-
up trial including Holocaust survivors with one or more
stress-response disorders (i.e. PTSD, depression, anxiety
and/or prolonged grief).
Participants will be randomly assigned (see Fig. 1) to
either the LRT (in addition to the social club) or a sup-
portive control group (social club only). The treatment
includes 20–25 sessions. The participant timeline is pre-
sented as SPIRIT schedule in Fig. 1.
Enrolment into one of the two groups will be done
consecutively during the recruitment phase. The treat-
ment phase takes approx. Nine months. Before and after
the treatment phase, participants in both groups will be
assessed. Follow-up will take place at 6 month post-
treatment. All assessments will be conducted by blind
assessors.
Sample
The sample consists of Holocaust survivors, i.e. Israeli
individuals who were born in 1945 or earlier in Europe
and experienced persecution, concentration camp, wit-
nessed torture and death, or who survived in hiding
and/or who experienced other traumatic events by the
Nazi regime during WWII.
Each participant is diagnosed with either full or sub-
syndromal PTSD, depressive disorder (major depression,
minor depression), anxiety disorder, or prolonged grief
disorder.
Recruitment
The participants will be recruited from ten centres of
Amcha in Israel. Mean age of Holocaust survivors at-
tending the social club at Amcha centres is currently (in
the year 2020) 89 years, the youngest were born in 1945.
About 30% were born between 1935 and 1945 (now 75–
85 years old), 50% between 1925 and 1935 (now 85–95
years old) and 20% were born before 1925 (now over 95
years old).
Study participants will be recruited from current and
new social club members. During the time of the re-
search project, there will be active advertisements in the
community and at medical practices in order to intro-
duce Amcha, its social clubs and the study treatment.
The fact that Amcha is present in 15 cities across Israel,
has a very good reputation in the country, and is work-
ing with other medical institutions, makes the proposed
study highly feasible.
Inclusion and exclusion criteria
Inclusion criteria are:
 Being a Holocaust survivor, i.e. born in 1945 or
earlier in Europe and having experienced
persecution, concentration camp, witnessed torture
or death, or been forced to survive in hiding and/or
experienced other traumatic events by the Nazi
regime during WWII.
 Diagnosis of full or subsyndromal PTSD, depressive
disorder (major depression, minor depression),
anxiety disorder, or prolonged grief disorder.
 Participants do not receive any individual
psychotherapy during the time of the study (except
for LRT in the intervention condition).
 Participants must have been informed about the
study and must have given written informed
consent. This includes that he/she is willing to be
randomly assigned to one of the study groups.
Forstmeier et al. BMC Psychiatry          (2020) 20:186 Page 4 of 13
Fig. 1 (See legend on next page.)
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Exclusion criteria are: Probable dementia (Mini Mental
Status Examination, MMSE < 26); acute psychotic dis-
order; acute suicidality.
Withdrawal criteria
Participation in the study is voluntary. There are no
negative consequences for non-participation or dropping
out. Individuals who refuse participation or drop out get
medical and psychosocial care as usual. Although an in-
crease of suicidality is not expected during treatment,
participants will be withdrawn from the study by the re-
search team in case of heightened suicidality.
Informed consent
The objects and goals, detailed information about assess-
ment and therapy as well as the procedure of randomisa-
tion will be explained to the subjects. The information
will also be given in printed form for the subjects. Writ-
ten informed consent will be obtained from all partici-
pants prior to inclusion. Participants who cannot give
their informed consent will not be included in the study.
Sample size
Previous studies on PTSD treatments found a large
mean effect size for PTSD outcomes (controlled d = 0.8
with a supportive control group) [26]. Studies on LRT
also found a large mean (pre-post) effect size in older in-
dividuals with a mental disorder (in most studies depres-
sion) (g = 1.3; 19). We rest our sample size calculation
on the conservative assumption of a medium-to-large ef-
fect size (d = 0.7, corresponds to f = 0.35). The sample
size was calculated using G*Power 3.1.0 [27]. Given an
α = 0.05 and a test power 1-β = 0.80, a total sample size
of n = 50 (each group n = 25) is required. We assume a
rather conservative drop-out rate of about 40% from en-
rolment to follow-up. Thus, we propose to start with 80
participants at enrolment (i.e. 40 in the LRT and 40 in
the control group).
Randomisation
After providing informed consent and receiving a base-
line assessment, the participants will be individually
assigned to a group at random. The allocation ratio for
randomisation into either the treatment or control group
is 1:1. The randomisation will be performed by a
randomization list that was generated by a computer
programme (RandList) beforehand, independently oper-
ated by the principal investigator at the University of
Siegen, Germany, who does not have any personal con-
tact with the participants. The results of the
randomization will be sent to the study coordinator in
Jerusalem, Israel, who will contact the therapist to ex-
plain the next steps.
Interventions
Life-review therapy
The LRT-HS applied in this study includes six modules.
1. Module 1, “Introduction and motivation,
diagnostics and goal setting”, includes an
introduction into life-review therapy (i.e. rationale,
tools, life book), an assessment of symptoms, diag-
nostics and individualized goal setting.
2. Module 2, “Structured life review”, is one of two the
main parts of the therapy. The structure and
content of this life review is adapted from that
presented by Haight and Haight [22], which has
already been applied with older trauma patients
[21]. Four phases can be distinguished: childhood (2
sessions), adolescence (1 session), adulthood (2
sessions) and integration (2 sessions).
3. Module 3, “Narrative confrontation with the
stressor”, is the second of the two main parts of the
therapy. This module is positioned in between the
sessions of module 2, exactly before the session in
which the life phase is discussed in which the
traumatic event has happened. If the Holocaust
happened during the childhood, module 2 starts
with the early childhood (birth until Holocaust),
followed by module 3 (Holocaust experiences), and
followed by the rest of module 2. This form of
narrative exposure has been proven to be effective
in the treatment of PTSD [13, 21, 28].
4. Module 4, “Examining stuck points”, continues with
cognitive aspects of the integration sessions of the
life review. It addresses dysfunctional thoughts that
the patient often ruminates about and helps him/
her to change them into helpful ones. Two
strategies are used: Socratic dialogue in order to
help the patient to challenge dysfunctional thoughts
and formulate new, helpful thoughts, and a letter to
the child/adolescent/young adult that the patient
has been when he/she experienced the Holocaust.
5. Module 5, “Recapturing life”, focuses on changes in
behaviour (social contacts, pleasant activities) that
(See figure on previous page.)
Fig. 1 SPIRIT schedule of enrolment, treatment, and assessments. Abbreviations: DASS-21: Depression Anxiety Stress Scale-21; GDS: Geriatric
Depression Scale; LSI: Life Satisfaction Index; MMSE: Mini Mental Status Examination; PCL-5: PTSD Checklist for DSM-5; PHQ-9: Patient Health
Questionnaire 9; PTGI: Posttraumatic Growth Inventory; PTCI: Posttraumatic Cognitions Inventory; PTSD: Posttraumatic stress disorder; RFS:
Reminiscence Functions Scale
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have already been stimulated by life review and are
continued in this module.
6. Module 6, “Closing the therapy”, is the final session
with a review of the therapy sessions and a planning
of the next steps after therapy.
Session duration is usually 50 min (most sessions) or
60–90min (module 3). The interventions are described
in Table 1 in more detail.
Standardization of procedures: Therapists use a man-
ual of this LRT-HS, which includes descriptions of the
content of each session and material for the sessions. Be-
cause of the research setting, therapists will document
what happens during the sessions in detail on checklists,
i.e. which interventions they had applied and whether
(and why) they had stressed one point more than an-
other. Working sheets and interview guidelines are in-
cluded in the manual as well. Adherence to the
treatment manual is ensured by the intensive training
before the intervention phase, the regular supervision
and the examination of the session documentations.
Psychotherapists: The LRT-HS will be administered
by trained psychotherapists, i.e. psychologists, psychia-
trists and clinical social workers. All psychotherapists
have a master’s degree in psychology, medicine or
clinical social work. Furthermore, all participating
psychotherapists will be trained for this intervention
by a panel of experts and supervisors in the field of
psychotherapy for older age (Dr. E. van der Hal, Dr.
M. Auerbach, Dr. D. Brom, Dr. S. Forstmeier). A
two-day workshop will precede the intervention
phase. Supervision sessions will take part every month
(i.e. about 5 sessions per patient). All sessions will be
documented in a structured form and will be
reflected upon in the supervision sessions.
Pilot data: We applied the described treatment
programme with a few participants and found that they
accepted it and rate the treatment as very helpful. In




Module 1: Introduction and motivation, diagnostics and goal setting
1 Introduction and
motivation
Introduction to and rationale of life review; tools (photos and other objects); life book; organizational issues
2 Diagnostics Diagnostic investigation of symptoms, resources and social factors; overview over biography (“timeline”)
3 Goal setting Setting individual goals; preparation for first life review session
Module 2: Structured life review
4–5 Childhood Questions on childhood; life book
6 Adolescence Questions on adolescence; life book
7–8 Adulthood Questions on adulthood; life book
9–10 Integration Summary and integration questions
Module 3: Narrative confrontation with the stressor
11 Pre-Holocaust experiences Getting an overview about the experiences; clarifying the context of a single event; details of a single event;
ending the narrative; making meaning of the event (often in the following session)
12–13 Holocaust experiences Getting an overview about the experiences; clarifying the context of a single event; details of a single event;
ending the narrative; making meaning of the event (often in the following session)
14 Post-Holocaust
experiences
Getting an overview about the experiences; clarifying the context of a single event; details of a single event;
ending the narrative; making meaning of the event (often in the following session)
Module 4: Examining stuck points




Challenging dysfunctional thoughts (e.g. Socratic dialogue); formulating functional thoughts; introducing the
exercise of writing a letter to the child-self
17 Letter to the child-self Reading the letter out loud; summarising the most important insights and conclusions for the future
Module 5: Recapturing life
18 Social contacts Sharing biographic events and insights; reading the trauma narrative to relatives; maybe handing over the
biography to relatives
19 Pleasant activities Individual list of pleasant activities; planning activities; discussing problems with pleasant activities
Module 6: Closing the therapy
20 Concluding session Re-examining goals; evaluation of interventions; planning the future
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addition, symptoms were reduced to a clinically signifi-
cant degree.
Supportive control group
Supportive control groups are often used in PTSD treat-
ment studies because they offer both a treatment (in
contrast to a waiting list control group) and at the same
time are less effective than state-of-the-art treatments
(between d = 0.8; 26). We implement a control group
with social support in a group format that has a long
tradition in all Amcha centres. As described above, it is
called “social club” and has the goal of exploring and
strengthening the participants’ individual and social re-
sources when talking about current interpersonal prob-
lems, personal decisions and plans and hopes for the
future. It is a meeting place which answers the need to
meet other people and take part in social interaction. It
provides activities like films, lectures, courses in art,
music, memory improvement, gymnastics, languages
(English, Yiddish), visits to interesting places, birthday
celebrations, discussions of relevant issues, etc. Import-
antly, there are no trauma-focused interventions in the
supportive group. This is a fundamental difference to
the treatment group. Taken together, participants in the
control group receive supportive attention, which is eth-
ically acceptable since the participant’s need to talk and
relate is met. At the same time, using this control group
is methodologically appropriate because the likelihood of
a treatment effect is expected to be smaller than that in
the LRT group. Moreover, recruitment of study subjects
will not be compromised when using this control group.
Members of the staff of Amcha, who are independent of
the LRT interventionists, will provide the control inter-
vention. Control group members may receive LRT or
other psychotherapy after the follow-up assessment.
Records are kept in regard to which social club meet-
ings each participant (treatment and control group) has
attended in order to be able to monitor the type and fre-
quency of social club meetings.
Assessment
Eligibility screening
Before inclusion into the study, diagnostic interviews are
conducted by student research assistants with experience
and training in the assessment of PTSD, depression,
anxiety disorder, prolonged grief disorder and related
disorders, and in the administration of structured inter-
views. The following self-report measures are used in
the context of a clinical interview:
 PTSD: The PTSD Checklist for the “Diagnostic and
Statistical Manual of Mental Disorders 5” (DSM-5)
(PCL-5) is used [29]. It is a 20-item self-report meas-
ure that assesses the 20 DSM-5 symptoms of PTSD.
It also makes it possible to come to a probable PTSD
diagnosis according to DSM-5 criteria [30]. The
questionnaire has been found reliable and valid in an
Israeli sample [31].
 Depressive disorder: The Patient Health
Questionnaire (PHQ-9) is a widely used 10-item
self-report measure of depressive symptoms with
well-established psychometric properties [32]. It
makes it possible to diagnose a probable major and
minor depressive disorder [33] and is sensitive to
change [34]. The Hebrew version has also been
found to be reliable and valid [35].
 Prolonged grief disorder is diagnosed according to
the criteria proposed for the “International
Classification of Diseases 11” (ICD-11) [36]. The
validated Hebrew version is used [37].
To screen for potential cognitive impairment, the
MMSE [38] in its Hebrew version [39] is used. The clin-
ical work prior to registration will include anamnesis,
family history, psychiatric, neurological, internal status
and neuropsychological testing (MMSE).
Study outcome measures (primary and secondary
endpoints)
All scales are applied in Hebrew language and have been
tested for validity and reliability in this language. Pri-
mary endpoints are PTSD and depressive symptoms:
 PTSD symptoms: The PTSD Checklist for DSM-5
(PCL-5) is used [29] in its Hebrew version [31], a
20-item self-report measure that assesses the 20
DSM-5 symptoms of PTSD.
 Depressive symptoms: The Patient Health
Questionnaire (PHQ-9) and the Geriatric
Depression Scale (GDS) are used. The PHQ-9 is a
widely used 10-item self-report measure of depres-
sive symptoms with well-established psychometric
properties [32] in its Hebrew version [35]. The GDS
is a 15-item self-report measure developed for use
with older people [40]. It has been found reliable
and valid in an Israeli sample [41].
Secondary endpoints are:
 Grief symptoms: The ICD-11 Symptom-Diagnostic
Test for Prolonged Grief Disorder (PG-ICD-11)
questionnaire is a self-report measure of grief symp-
toms based on the proposal for the diagnostic as-
sessment of PGD for ICD-11 [42]. It includes two
core symptoms (yearning, preoccupation) and five
additional symptoms (e.g. anger, survivor’s guilt).
There has been research on the optimum symptom
threshold [43]. The Hebrew version is used [37].
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 Complex PTSD symptoms: The complex PTSD part
of the ICD-11 Trauma Questionnaire [44] is used to
measure complex PTSD symptoms. This 16-item
measure captures four symptom clusters with two
relating to affect regulation characterised by hyper-
activation or deactivation, negative self-concept and
disturbed relationships. The validated Hebrew ver-
sion is used [37].
 Anxiety symptoms: The Depression Anxiety
Stress Scale-21 (DASS-21) is a 21-item self-
report questionnaire evaluating current anxiety,
stress and depression levels [45] in its Hebrew
version. The questionnaire has also been used in
older people [46].
 Dysfunctional thoughts: The Posttraumatic
Cognitions Inventory (PTCI) [47] assesses typical
dysfunctional trauma-related thoughts and beliefs
in the domains of negative cognitions about the
self (21 items, e.g. “My life has been destroyed
by the trauma”), negative cognitions about the
world (7 items, e.g. “The world is a dangerous
place”) and self-blame (5 items, e.g. “Someone
else would not have gotten into this situation”).
The questionnaire has been found reliable and
valid in an Israeli sample [48].
 Reminiscence style: The Reminiscence Functions
Scale (RFS) [49] is used to assess seven different
reminiscence styles (boredom reduction, death
preparation, identity/problem-solving, conversation,
intimacy maintenance, bitterness revival, and teach/
inform). A 28-item version has been shown to have
the same factor structure [50]. We apply a Hebrew
translation of the 28-item version [51].
 Positive well-being: The Life Satisfaction Index (LSI)
[52] is used to measure positive aspects of well–be-
ing among older people. The LSI was intended to
measure five components that had been identified in
a review of previous measurement instruments.
These include zest for life (as opposed to apathy),
resolution and fortitude, congruence between de-
sired and achieved goals, positive self-concept and
mood tone. Positive well-being is indicated by the
individual taking pleasure in his/her daily activities,
finding life meaningful, reporting a feeling of success
in achieving major goals, a positive self-image and
optimism. The validated Hebrew version is used
[53].
 Posttraumatic growth: The Posttraumatic Growth
Inventory (PTGI) [54] measures positive change
after traumatic experience on the following
subscales (21 items): New possibilities, relating to
others, personal strength, appreciation of life and
spiritual change. The questionnaire is reliable and
valid in an Israeli sample [55].
Outcome variables were assessed using these self-
report instruments at three points in time (pretest, post-
test, follow-up).
Predictors
Factors that might influence the endpoints will also be
assessed:
 Age at time of trauma (young age is associated with
more symptoms)
 Gender (female gender is associated with more
symptoms)
 Educational level, i.e. years of school education
 Cognitive status (assuming low status is associated
with more symptoms)
 Trauma severity, i.e. number of traumatic events,
months/years experiencing the Holocaust, incl.
Critical life events in the previous 5 years.
In addition, several sociodemographic variables will
also be included in the assessment, such as age, sex, fam-
ily status, education and occupation.
Assessment of safety
Participants will be regularly screened for suicidality. In
case of increased suicidality - although not expected -
participants will be taken out of the study by the re-
search team. For safety and for keeping an overview over
the study, a case report form (CRF) will be completed
after each information, assessment or therapy session.
The CRF contains checklists, test results, information
about the participant (other therapies, medications,
problems etc.), adverse events, date of the assessments
and name of the investigators.
Data analysis
Statistical analysis
Several analytic strategies are planned to test the efficacy
of the treatment. First, analyses of variance (ANOVAs)
will be conducted to compare the mean outcome in
PTSD and depressive symptoms (primary endpoints) as
well as the secondary endpoints. The age at the time of
trauma, gender, educational level, cognitive status and
trauma severity will be considered as covariates.
Secondly, individual growth curves will be analysed,
i.e. rates and shapes of change will be examined, and in-
dividual growth curves will be compared to investigate
differences.
Thirdly, multivariate analyses will be used to test the
effect of the treatment with regard to primary and sec-
ondary outcomes. In this way, correlations between the
outcome measures can be considered. Post hoc analyses
will be performed following a significant overall effect.
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Methods against bias
The proposed study requires several methods to avoid
bias.
Selection bias: The randomisation procedure is the
gold standard to avoid this bias. Random numbers will
therefore be generated in advance. The randomisation
procedure will be controlled by comparing the two
groups with regard to possible confounders, i.e. age at
the time of trauma, gender, educational level, diagnosis,
cognitive status and trauma severity.
Detection bias: The baseline assessment is done before
randomisation to avoid this bias. In addition, the thera-
pists will not collect any outcome data at posttest and
follow-up. This will be done by blinded members of the
research team (clinical psychologists or psychiatrists or
advanced master students in clinical psychology).
Performance bias: To counteract this bias, the stand-
ardisation procedure (manual, extensive training, docu-
mentation of sessions, supervision) is established.
Attrition bias: Statistical analysis will include tech-
niques to minimise possible attrition bias, i.e. intention-
to-treat analysis and imputing missing data. In case of
drop-outs, it is intended to continue data collection
whenever possible.
Handling of missing values and drop-outs
A complete data set is available if all three test times
(pretest, posttest, follow-up) have been performed. A
drop-out can occur, (1) if the participant does not
complete the pretest, (2) decides after information or
after randomisation against participation, or (3) starts
with the treatment, but discontinues it.
If less than 20% of the items of one self-report instru-
ment are missing, missing values are imputed by the
mean of the scale of this participant. If a whole scale is
missing, the value will be imputed by the expectation-
maximation (EM) algorithm.
Data handling
There are three types of data that is developed or col-
lected in this study: the LRT manual, the “life book” and
the assessment data (pre, post and follow-up). The LRT
manual will be published by an international publisher
in English with the aim that it will be used throughout
the world in the treatment of Holocaust survivors and
other older, multiply traumatised individuals.
The life book is a folder that the patient fills with pho-
tos, important written (positive and negative) memories
from all life phases, the trauma narratives, helpful
thoughts, personal and social strengths, information
about the family etc. This life book will remain in the
possession of the patients and will not be analysed. It is
a by-product of the therapy. However, if the patient
wishes, he/she can submit parts of this life book as a
testimony to Yad Vashem (www.yadvashem.org), an Is-
raeli institution that preserves a database of Holocaust
victims and their testimonies. The participants might
wish to pass information on his/her biography to the
public, but we do not request it, it is the autonomous
decision of each individual Holocaust survivor.
The assessment data (information on symptoms) must
also be considered very sensitive data. Therefore, the
data will be stored in an anonymous form. Storage and
backup will be ensured during the project by the princi-
pal investigator in cooperation with the representative of
the IT department of the Centre for Information and
Media Technology (ZIMT) of the University of Siegen.
The long term archiving will be done in the data reposi-
tory of the ZIMT.
The data and all associated documentation will be
stored for a minimum of 10 years after the completion
of the study, including the follow-up period.
Communication between German and Israeli teams
We plan to communicate between the German and Is-
raeli team in three ways. First, we plan monthly skype
meetings to discuss ongoing, day-to-day issues such as
recruitment and data entry. Second, there will be one
face-to-face meetings per year, either in Germany or in
Israel. These meetings will be used to discuss questions
that have emerged in relation to supervision, adherence
to the treatment manual, training of new student assis-
tants in data entry, interpretation of pre-post analyses
and pre-follow-up analyses etc. Third, data exchange be-
tween Israel and Germany is ensured via the web-based
data entry system.
Regulatory issues
This is an RCT with individuals in need of special pro-
tection and, thus, requires particular ethical
considerations.
Ethics approval
The approvals of the ethics committee of the German
Association of Psychology (Deutsche Gesellschaft für
Psychologie, DGPs, 11/01/2016, ref.: SF_112015) and the
ethics committee of the Hebrew University of Jerusalem,
School of Social Work (15/05/2017) have been obtained.
The study will be conducted in accordance with princi-
ples enunciated in the current Declaration of Helsinki,
the guidelines of good clinical practice (GCP) issued by
the International Conference on Harmonisation (ICH)
and the German and Israeli regulatory authority’s
requirements.
Participation in the study is voluntary. There are no
negative consequences for non-participation or dropping
out. Individuals who refuse participation or drop out will
get medical and psychosocial care as usual. While ethical
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problems might arise due to randomisation, the control
group is a social support group, so participants in both
study groups will benefit if they enrol in the study.
Consent
Consent to joining the study will be requested from each
participant only after a full verbal and written explan-
ation has been given, an information leaflet offered and
time allowed for consideration; such declarations of con-
sent will be signed. The right of the participant to refuse
to participate without giving reasons will be respected.
After the participant has entered the study, the clin-
ician will remain free to provide alternative treatment to
that specified in the protocol at any stage if he/she feels
it is in the participant’s best interest, but the reasons for
doing so will be recorded. In these cases, the participants
remain within the study for the purposes of follow-up
and data analysis. All participants are free to withdraw at
any time from the treatment without giving reasons and
without prejudicing further treatment.
Confidentiality
The principal investigator will preserve the privacy of
participants taking part in the study and is registered
under the Data Protection Act. Assessment and process-
ing of all personal data is done pseudonymised, i.e. with
a number and without indication of the participant’s
name. A coding list on paper, which is accessible only to
the study management, is used to link names with num-
bers. It will be destroyed after termination of data collec-
tion, whereupon the data will become anonymised.
Audits
The study may be subject to inspection and audit by
regulatory bodies to ensure adherence to GCP, national
law, and regulatory requirements.
Adverse events
Adverse events (AEs) are any negative medical or psy-
chological occurrence in the study subject, e.g. worsen-
ing of symptoms. Serious adverse events (SAEs) are any
negative and unexpected medical or psychological occur-
rence or effect that: results in death; is life-threatening
(refers to an event in which the subject was at risk of
death at the time of the event; it does not refer to an
event which hypothetically might have caused death if it
were more severe); necessitates hospitalisation, or pro-
longation of existing inpatients’ hospitalisation; results in
persistent or significant disability or incapacity; is a con-
genital anomaly or birth defect.
Medical or psychological judgement will be exercised
in deciding whether an AE is serious in other situations.
Important AEs that are not immediately life-threatening
or do not result in death or hospitalisation, but may
jeopardise the subject or may require intervention to
prevent one of the other outcomes listed in the defin-
ition above, will also be considered serious.
Reporting procedures: All adverse events will be re-
ported. Depending on the nature of the event, the
reporting procedures below will be followed. Any ques-
tions concerning adverse event reporting must be di-
rected to the principal investigator in the first instance.
 Non serious AEs: All such events, whether expected
or not, will be recorded.
 Serious AEs: An SAE form will be completed and
faxed to the principal investigator within 24 h.
However, hospitalisations for elective treatment of a
pre-existing condition do not need reporting as
SAEs.
The principal investigator will assess whether the
event is:
 ‘Related’, i.e. resulted from the administration of any
of the research procedures; and
 ‘Unexpected’, i.e. an event that is not listed in the
protocol as an expected occurrence.
Reports of suspected related and unexpected SAEs
(SUSARs) will be submitted within 15 days or within 7
days for fatal or life-threatening SUSARs, respectively, of
the investigator becoming aware of the event to the Eth-
ics Committee.
Discussion
Life-review therapy for Holocaust survivors (LRT-HS)
was developed to bring together LRT and a trauma-
focused approach used in CBT treatment of PTSD.
While LRT serves as an age-specific treatment approach
for older people which meets their need to review their
own life, to evaluate gains and losses and to find mean-
ing, and was found to be very effective as a treatment for
depression in old age [19] as well as PTSD [21], the
trauma-focused approach aims at reconstructing the
memories of traumatic events and transforming them
into a coherent narrative [56]. The fragmentation of
trauma-related memory hinders traumatised older
people to review their lives. LRT-HS offers a framework
to process trauma-related memories and integrate them
into a coherent life story.
This RCT is, to our knowledge, the first to investigate a
psychotherapy programme for Holocaust survivors, and the
third to investigate a PTSD treatment approach in old age.
The two previous RCTs investigated an internet-based writ-
ing therapy called Integrative Testimonial Therapy (ITT)
with WWII survivors combining cognitive-behavioural and
life review elements [8, 9] and a prolonged exposure
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therapy with older veterans with military service-related
PTSD [10, 11]. While the latter did not try to modify the
prolonged exposure approach to this age group, ITT inte-
grates trauma-focused and life review elements, which is
similar in our approach. The most important differences
between LRT-HS and ITT are the setting (face-to-face vs.
internet-based writing), the intensity, i.e. number of ses-
sions (20–25 vs. 11), and the target group (multiply trauma-
tised Holocaust survivors vs. German WWII survivors).
This RCT will not only inform us of the efficacy of this
treatment approach with Holocaust survivors, it also has
the potential to be applied to other multiply traumatised
older people. Civil war refugees will eventually get old and
need an age-adequate trauma treatment. There is already
the idea to combine LRT and exposure therapy to veterans
[57]. But also aging survivors of traumatisation in childhood
or adolescence will become a larger group requiring psy-
chotherapy as society is aging. Thus, the results of this
study will have implications for the treatment and rehabili-
tation of patients many years after traumatic events.
Supplementary information
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0.1186/s12888-020-02600-5 .
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